Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Pharmacia & Upjohn reveals novel compounds and novel methods of treating NIDDM

Feb. 13, 1998

Sankyo researches new antidiabetic agents

Feb. 13, 1998

Goralatide: a candidate hematopoietic agent from Beaufour Ipsen

Feb. 12, 1998

Adenosine agonists with antilipolytic activity described by Glaxo

Feb. 12, 1998

Macritonin clinical trial update

Feb. 11, 1998

SGLT inhibitors under evaluation at Tanabe as antidiabetic agents

Feb. 11, 1998

Novel compound MK6059 isolated by Meiji Seika/Mitsubishi Chemical

Feb. 11, 1998

Zoledronate compared to other bisphosphonates in rat models of bone loss

Feb. 10, 1998

MMAS results discussed at world congress

Feb. 10, 1998

Pernasal testosterone: a novel administration route for androgenic substitution

Feb. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...